Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wilate prophylaxis in VWD
NCT04052698Phase 3Completed
- Sponsor
- Octapharma
- Start
- Jun 2020
- Primary completion
- Apr 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
A Phase 3 trial of von Willebrand factor concentrate in von Willebrand disease (VWD), sponsored by Octapharma. Started Jun 2020; status: completed.
02
Drugs
von Willebrand factor concentrate
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on NCT04052698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04052698.